Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_246146645c44b223b6a2e9a82d4287a9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397d03534b0c050f40ea707820b01c8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3528e1c6eff97cba012d542043c2376d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1798936d1253cfc1a4e42d58f8f0a4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dae6882dd0359d2007b426645f6f3e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a78ad413a45e68dad72e4e1ae8b4342 |
publicationDate |
2020-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020113942-A1 |
titleOfInvention |
Application of fumarate and pharmaceutically acceptable salts thereof in preparation of medicines for treating ferroptosis related diseases |
abstract |
Use of fumarate and pharmaceutically acceptable salts thereof in preparation of medicines for treating ferroptosis related diseases. The fumarate comprises dimethyl fumarate and/or monomethyl fumarate. |
priorityDate |
2018-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |